Cigna Group (NYSE:CI) Issues FY 2026 Earnings Guidance

Key Points

• Cigna issued FY 2026 guidance of approximately $30.45 in EPS and $280 billion in revenue, both below analyst consensus estimates of $30.51 EPS and $287.2 billion in revenue.
• Analysts maintain a generally positive view, with 15 Buy ratings and eight Holds, resulting in a “Moderate Buy” consensus and an average price target of $337.10.
• Cigna’s latest quarter exceeded EPS expectations, reporting $7.78 versus the $7.60 consensus, while revenue increased 6.7% year over year to $70.04 billion; the company also pays a $1.56 quarterly dividend.

Cigna Group (NYSE:CI - Get Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 30.450- for the period, compared to the consensus earnings per share estimate of 30.510. The company issued revenue guidance of $280.0 billion-$280.0 billion, compared to the consensus revenue estimate of $287.2 billion.

Analysts Set New Price Targets

Several equities analysts recently commented on CI shares. Weiss Ratings restated a "hold (c)" rating on shares of Cigna Group in a research report on Thursday, August 27th. Mizuho lifted their price target on Cigna Group from $330.00 to $340.00 and gave the company an "outperform" rating in a research report on Monday, June 8th. Wells Fargo & Company boosted their price target on shares of Cigna Group from $305.00 to $307.00 and gave the stock an "equal weight" rating in a research note on Friday, July 31st. Wall Street Zen upgraded Cigna Group from a "hold" rating to a "buy" rating in a research report on Saturday. Finally, Sanford C. Bernstein boosted their price objective on shares of Cigna Group from $371.00 to $381.00 and gave the stock an "outperform" rating in a report on Thursday, July 9th. Fifteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $337.10.

Cigna Group Price Performance

CI opened at $274.94 on Wednesday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The stock's 50 day simple moving average is $279.78 and its 200 day simple moving average is $280.51. The firm has a market cap of $72.65 billion, a price-to-earnings ratio of 11.38, a PEG ratio of 0.93 and a beta of 0.31. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts' consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. During the same quarter in the prior year, the firm posted $7.20 earnings per share. The business's quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, analysts predict that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th were paid a $1.56 dividend. The ex-dividend date of this dividend was Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. Cigna Group's dividend payout ratio (DPR) is presently 25.82%.

Insider Buying and Selling

In other news, insider Nicole S. Jones sold 19,436 shares of Cigna Group stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the sale, the insider owned 27,256 shares of the company's stock, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the firm's stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares of the company's stock, valued at $1,435,304.65. This trade represents a 10.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 22,730 shares of company stock valued at $6,293,359 in the last ninety days. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Company Profile

The Cigna Group NYSE: CI is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.